- Trials with a EudraCT protocol (250)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (12)
250 result(s) found for: Dopamine.
Displaying page 1 of 13.
EudraCT Number: 2006-000832-28 | Sponsor Protocol Number: LWH0642 | Start Date*: 2006-07-04 |
Sponsor Name:Liverpool Women's NHS Foundation Trust | ||
Full Title: Dopamine pharmacokinetics in extremely premature infants: a pilot study | ||
Medical condition: Neonatal hypotension | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-000155-12 | Sponsor Protocol Number: 2018_49 | Start Date*: 2020-05-12 |
Sponsor Name:InBrain Pharma SAS | ||
Full Title: A new concept of continuous dopaminergic stimulation by cerebroventricular administration of A-dopamine (dopamine stored in anaerobia) for severe motor fluctuations in Parkinson’s disease? | ||
Medical condition: Proof of concept study: prospective, monocentric, controlled randomized study according a cross over design with 2 groups: cerebroventricular administration of A-dopamine versus optimized oral trea... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001352-36 | Sponsor Protocol Number: DOPAREAD1 | Start Date*: 2014-12-19 |
Sponsor Name: | ||
Full Title: The effect of dopamine on reading motivation and achievement. | ||
Medical condition: There are no medical conditions or diseases under investigation. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004970-16 | Sponsor Protocol Number: CS15-033 | Start Date*: 2017-05-30 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: Imaging the functional and molecular impact of poly-unsaturated fatty acids on dopamine-dependent cognitive functions: a combined [11C]-(+)-PHNO PET/MRI study at different stages of cognitive impai... | |||||||||||||
Medical condition: This study will assess the effects of poly-unsaturated fatty acids on working memory (measured using an n-back test) in healthy volunteers, in subjects who are at high risk for developing a psychot... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001284-12 | Sponsor Protocol Number: PA-01 | Start Date*: 2014-11-19 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: The Role of the Dopamine D2 Receptor System in Pornographic Addiction – A [11C]-Raclopride PET Study | ||
Medical condition: pornographic addiction | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004244-37 | Sponsor Protocol Number: 13HH1824 | Start Date*: 2014-02-21 | |||||||||||
Sponsor Name:Imperial College London | Imperial College NHS Healthcare Trust | |||||||||||||
Full Title: The control of brain networks after traumatic brain injury: a neuroimaging and neuropsychological study of dopamine and cognition | |||||||||||||
Medical condition: Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004880-33 | Sponsor Protocol Number: 18F-FDOPA-BUP-ESC | Start Date*: 2023-01-20 |
Sponsor Name:Medical University of Vienna, University Department of Psychiatry and Psychotherapy | ||
Full Title: Reward-specific changes of cerebral dopamine synthesis in healthy volunteers and depressed patients | ||
Medical condition: Major Depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021403-24 | Sponsor Protocol Number: 001 | Start Date*: 2010-11-10 | |||||||||||
Sponsor Name:North Lincolnshire and Goole NHS Foundation Trust | |||||||||||||
Full Title: A Prospective Pilot Study to Investigate the Effectiveness of Quinagolide in the Improvement of Psychological Symptoms Associated with Hyperprolactinaemia. | |||||||||||||
Medical condition: Hyperprolactinaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001485-41 | Sponsor Protocol Number: AMAD001 | Start Date*: 2005-04-20 |
Sponsor Name:Institute for Neurodegenerative Disorders | ||
Full Title: A single-blinded assessment of the short-term effects of cabergoline vs. carbidopa/levodopa on SPECT dopamine transporter density in out-patient subjects with Parkinson’s Disease | ||
Medical condition: Approximately 120 recently diagnosed/early Parkinson’s disease subjects, who are untreated (see exclusionary criteria). | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: AT (Ongoing) GB (Prematurely Ended) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-006302-28 | Sponsor Protocol Number: OXYGENE | Start Date*: 2012-07-11 |
Sponsor Name:UNIVERSITA' DEGLI STUDI DI PARMA | ||
Full Title: Dopamine modulation of oxytocin prosocial effects | ||
Medical condition: HEALTHY VOLUNTEERS. FOR PATIENTS WITH AUTISM OR SCHIZOPHRENIA | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005567-26 | Sponsor Protocol Number: TVN67 | Start Date*: 2007-09-03 |
Sponsor Name:University of Aachen | ||
Full Title: Effects of deep brain stimulation of the nucleus accumbens on the dopaminergic activity in patients with Gilles-de-la-Tourette-syndrome | ||
Medical condition: The participants under study are recruited from a sample of patients suffering from a severe form of the Gilles-de-la-Tourette-syndrome who are waiting to receive deep-brain stimulation of the ncl.... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000156-11 | Sponsor Protocol Number: S65914 | Start Date*: 2022-02-25 |
Sponsor Name:KU Leuven | ||
Full Title: Oxytocin and the development of attachment: Looking beyond the expected? | ||
Medical condition: General healthy population children (ages 8 - 13 years old). | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004062-41 | Sponsor Protocol Number: D2PET-2007 | Start Date*: 2007-08-13 |
Sponsor Name:Jarmo Hietala | ||
Full Title: Effect differences of conventional and newer atypical antipsychotics – Perphenazine and brain dopamine D2 receptor blockade | ||
Medical condition: Tutkittavat ovat terveitä. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004825-29 | Sponsor Protocol Number: IIS-2011-01 | Start Date*: 2011-11-30 |
Sponsor Name:Instituto de Investigaciones del Sueño | ||
Full Title: TREATMENT WITH ROTIGOTINE OF RLS PATIENTS WITH AN INSUFFICIENT RESPONSE TO DOPAMINE AGONIST WITH INTERMEDIATE HALF-LIFE. | ||
Medical condition: Restless Legs Syndrom | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000891-54 | Sponsor Protocol Number: REBOOT-II | Start Date*: 2016-11-28 |
Sponsor Name:Aging Research Center, Karolinska Institutet and Stockholm University | ||
Full Title: Effects of enhanced dopaminergic neurotransmission on working memory training efficiency in the healthy elderly - A prospective, single center, randomized, double blind, placebo controlled, paralle... | ||
Medical condition: No medical condition is under investigation. The project investigates normal age-related decline in intellectual abilities. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004139-74 | Sponsor Protocol Number: PB1 | Start Date*: 2005-04-20 |
Sponsor Name:Neurologisk afdeling F | ||
Full Title: Parkinson’s Disease: PET scan and evaluation of memantines pharmacological effect. (Parkinsons sygdom bedømt med PET skanning, herunder memantins farmakologiske effekt.) | ||
Medical condition: Parkinson's Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003131-38 | Sponsor Protocol Number: DOPA2016 | Start Date*: 2017-06-23 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: The effect of chlorpromazine (Largactil), a dopamine type 2-(D2-) receptor antagonist, on esophageal sensitivity in healthy volunteers: a randomized, double-blind, placebo-controlled study | ||
Medical condition: Increased esophageal sensitivity in refractory gastro-esophageal reflux disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002010-38 | Sponsor Protocol Number: SC3-90049-001 | Start Date*: 2005-11-21 |
Sponsor Name:Institut de Recherches Internationales Servier (I.R.I.S.) | ||
Full Title: Assessment of the acceptability of a sublingual formulation of piribedil (S90049), 10 to 30 mg on request (maximum 5 times a day) on the top of L-dopa and a dopamine agonist in advanced Parkinson D... | ||
Medical condition: Advanced Parkinson´s Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-020810-27 | Sponsor Protocol Number: IB-08-03 | Start Date*: Information not available in EudraCT |
Sponsor Name:Laboratoires BOIRON | ||
Full Title: Essai clinique contrôlé randomisé, multicentrique, évaluant l'efficacité de deux médicaments homéopathiques (Dopamine 5 CH et Serotoninum muriaticum 5 CH) chez l'enfant TDAH âgé de 3 à 7 ans (6 ans... | ||
Medical condition: TDAH (Trouble Déficit de l'Attention Hyperactivité) | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2022-001563-26 | Sponsor Protocol Number: NCT05355337 | Start Date*: 2022-10-03 | |||||||||||
Sponsor Name:Region Skåne | |||||||||||||
Full Title: Pramipexole for Anhedonic Depression (PRIME-PRAXOL) | |||||||||||||
Medical condition: The effect of nine weeks of treatment with the dopamine agonist Pramipexole in patients with depression with clinically significant anhedonia will be evaluated with symptom rating scales, blood and... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.